{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:36:38Z","timestamp":1791333398804,"version":"4.3.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T00:00:00Z","timestamp":1269648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00115-010-2948-1","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T11:31:29Z","timestamp":1269603089000},"page":"471-496","source":"Crossref","is-referenced-by-count":9,"title":["Entmarkungserkrankungen","Demyelinating disorders"],"prefix":"10.1007","volume":"81","author":[{"given":"T.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,27]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"crossref","unstructured":"Geurts JJ, Stys PK, Minagar A et al (2009) Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 282(1\u20132):12\u201320","DOI":"10.1016\/j.jns.2009.01.018"},{"key":"2948_CR2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707\u2013717","journal-title":"Ann Neurol"},{"key":"2948_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458506072189","volume":"13","author":"Pittock","year":"2007","unstructured":"Pittock SJ, Reindl M, Achenbach S et al (2007) Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler 13(1):7\u201316","journal-title":"Mult Scler"},{"key":"2948_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-007-0754-x","volume":"255","author":"Seewann","year":"2008","unstructured":"Seewann A, Enzinger C, Filippi M et al (2008) MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings. J Neurol 255(1):1\u201310","journal-title":"J Neurol"},{"key":"2948_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202(4):473\u2013477","journal-title":"J Exp Med"},{"key":"2948_CR6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"key":"2948_CR7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sc.2008.99","volume":"47","author":"Pawate","year":"2009","unstructured":"Pawate S, Sriram S (2009) Isolated longitudinal myelitis: a report of six cases. Spinal Cord 47(3):257\u2013261","journal-title":"Spinal Cord"},{"key":"2948_CR8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125(7):1450\u20131461","journal-title":"Brain"},{"key":"2948_CR9","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(11):3072\u20133080","journal-title":"Brain"},{"key":"2948_CR10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneurol.2009.152","volume":"66","author":"Magana","year":"2009","unstructured":"Magana SM, Pittock SJ, Lennon VA et al (2009) Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol 66(8):964\u2013966","journal-title":"Arch Neurol"},{"key":"2948_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR et al (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66(5):617\u2013629","journal-title":"Ann Neurol"},{"key":"2948_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","volume":"72","author":"Banwell","year":"2009","unstructured":"Banwell B, Kennedy J, Sadovnick D et al (2009) Incidence of acquired demyelination of the CNS in Canadian children. Neurology 72(3):232\u2013239","journal-title":"Neurology"},{"key":"2948_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","volume":"56","author":"Schwarz","year":"2001","unstructured":"Schwarz S, Mohr A, Knauth M et al (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56(10):1313\u20131318","journal-title":"Neurology"},{"key":"2948_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2006.05.049","volume":"247","author":"Franciotta","year":"2006","unstructured":"Franciotta D, Zardini E, Ravaglia S et al (2006) Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci 247(2):202\u2013207","journal-title":"J Neurol Sci"},{"key":"2948_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","volume":"66","author":"Brilot","year":"2009","unstructured":"Brilot F, Dale RC, Selter RC et al (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66(6):833\u2013842","journal-title":"Ann Neurol"},{"key":"2948_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"\u00c5str\u00f6m","year":"1958","unstructured":"\u00c5str\u00f6m KE, Mancall EL, Richardson EP (1958) Progressive multifocal leuko-encephalopathy. A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease. Brain 81:93\u2013111","journal-title":"Brain"},{"key":"2948_CR17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.148.3676.1477","volume":"148","author":"Zu","year":"1965","unstructured":"Zu Rhein GM, Chou SM (1965) Particles resembling papovavirions in human cerebral demyelinating disease. Science 148:1477\u20131479","journal-title":"Science"},{"key":"2948_CR18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","volume":"297","author":"Padgett","year":"1971","unstructured":"Padgett BL, Walker DL, Zu Rhein GM et al (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 297(7712):1257\u20131260","journal-title":"Lancet"},{"key":"2948_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.semcancer.2009.04.001","volume":"19","author":"Dalianis","year":"2009","unstructured":"Dalianis T, Ramqvist T, Andreasson K et al (2009) KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 19(4):270\u2013275","journal-title":"Semin Cancer Biol"},{"key":"2948_CR20","doi-asserted-by":"crossref","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","volume":"5","author":"Kean","year":"2009","unstructured":"Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5(3):e1000363","journal-title":"PLoS Pathog"},{"key":"2948_CR21","doi-asserted-by":"crossref","unstructured":"Egli A, Infanti L, Dumoulin A et al (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis","DOI":"10.1086\/597126"},{"key":"2948_CR22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/514032","volume":"176","author":"Weber","year":"1997","unstructured":"Weber T, Trebst C, Frye S et al (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176(1):250\u2013254","journal-title":"J Infect Dis"},{"key":"2948_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ et al (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4):375\u2013381","journal-title":"N Engl J Med"},{"key":"2948_CR24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","volume":"361","author":"Linda","year":"2009","unstructured":"Linda H, Heijne A von, Major EO et al (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361(11):1081\u20131087","journal-title":"N Engl J Med"},{"key":"2948_CR25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","volume":"361","author":"Wenning","year":"2009","unstructured":"Wenning W, Haghikia A, Laubenberger J et al (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361(11):1075\u20131080","journal-title":"N Engl J Med"},{"key":"2948_CR26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"Yousry","year":"2006","unstructured":"Yousry TA, Major EO, Ryschkewitsch C et al (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354(9):924\u2013933","journal-title":"N Engl J Med"},{"key":"2948_CR27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ncl.2008.03.007","volume":"26","author":"Weber","year":"2008","unstructured":"Weber T (2008) Progressive multifocal leukoencephalopathy. Neurol Clin 26(3):833\u2013854","journal-title":"Neurol Clin"},{"key":"2948_CR28","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA et al (2009) Progressive multifocal leukoencephalopathy following rituximab therapy in HIV negative patients: a report of 57 cases from the Research on Adverse Drug Event and Reports (RADAR) project. Blood 113:4834\u20134840","journal-title":"Blood"},{"key":"2948_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13550280500511741","volume":"11","author":"Gray","year":"2005","unstructured":"Gray F, Bazille C, Adle-Biassette H et al (2005) Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 11(Suppl 3):16\u201322","journal-title":"J Neurovirol"},{"key":"2948_CR30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","volume":"59","author":"Love","year":"2006","unstructured":"Love S (2006) Demyelinating diseases. J Clin Pathol 59(11):1151\u20131159","journal-title":"J Clin Pathol"},{"key":"2948_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004010000245","volume":"100","author":"Jellinger","year":"2000","unstructured":"Jellinger KA, Setinek U, Drlicek M et al (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100(2):213\u2013220","journal-title":"Acta Neuropathol"},{"key":"2948_CR32","unstructured":"Hainfellner JA, Budka H (1997) Neuropathology of human immunodeficiency virus related opportunistic infections and related neoplasms. In: Berger JR, Levy RM (eds) AIDS and the nervous system. Lippincott-Raven, Philadelphia, p 481\u2013515"},{"key":"2948_CR33","doi-asserted-by":"crossref","unstructured":"Tan K, Roda R, Ostrow L et al (2009) PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology","DOI":"10.1212\/01.wnl.0000343510.08643.74"},{"key":"2948_CR34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13550280600716604","volume":"12","author":"Wuthrich","year":"2006","unstructured":"Wuthrich C, Kesari S, Kim WK et al (2006) Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol 12(2):116\u2013128","journal-title":"J Neurovirol"},{"key":"2948_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0344-0338(11)80087-7","volume":"189","author":"Kuchelmeister","year":"1993","unstructured":"Kuchelmeister K, Gullotta F, Bergmann M et al (1993) Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 189(2):163\u2013173","journal-title":"Pathol Res Pract"},{"key":"2948_CR36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/313598","volume":"30","author":"Giudici","year":"2000","unstructured":"Giudici B, Vaz B, Bossolasco S et al (2000) Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30(1):95\u201399","journal-title":"Clin Infect Dis"},{"key":"2948_CR37","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/JVI.01809-06","volume":"81","author":"Lima","year":"2007","unstructured":"Lima MA, Marzocchetti A, Autissier P et al (2007) Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 81(7):3361\u20133368","journal-title":"J Virol"},{"key":"2948_CR38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/13550280152537175","volume":"7","author":"Du","year":"2001","unstructured":"Du Pasquier RA, Clark KW, Smith PS et al (2001) JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol 7(4):318\u2013322","journal-title":"J Neurovirol"},{"key":"2948_CR39","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.02657-08","volume":"83","author":"Khanna","year":"2009","unstructured":"Khanna N, Wolbers M, Mueller NJ et al (2009) JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 83(9):4404\u20134411","journal-title":"J Virol"},{"key":"2948_CR40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2990.1993.tb00460.x","volume":"19","author":"Kuchelmeister","year":"1993","unstructured":"Kuchelmeister K, Bergmann M, Gullotta F (1993) Cellular changes in the cerebellar granular layer in AIDS-associated PML. Neuropathol Appl Neurobiol 19(5):398\u2013401","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2948_CR41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/01.WNL.0000081306.86961.33","volume":"61","author":"Du","year":"2003","unstructured":"Du Pasquier RA, Corey S, Margolin DH et al (2003) Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 61(6):775\u2013782","journal-title":"Neurology"},{"key":"2948_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/NEN.0b013e3181912570","volume":"68","author":"Wuthrich","year":"2009","unstructured":"Wuthrich C, Cheng YM, Joseph JT et al (2009) Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 68(1):15\u201325","journal-title":"J Neuropathol Exp Neurol"},{"key":"2948_CR43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archneurol.2009.94","volume":"66","author":"Tallantyre","year":"2009","unstructured":"Tallantyre EC, Paine SM, Sharp CP et al (2009) Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation. Arch Neurol 66(8):1021\u20131024","journal-title":"Arch Neurol"},{"key":"2948_CR44","doi-asserted-by":"crossref","unstructured":"Huang D, Cossoy M, Li M et al (2007) Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol","DOI":"10.1002\/ana.21085"},{"key":"2948_CR45","doi-asserted-by":"crossref","unstructured":"Gold R, Hartung HP, Hohlfeld R et al (2009) Therapy of multiple sclerosis with monoclonal antibodies Akt Neurol 36(7):334\u2013344","DOI":"10.1055\/s-0029-1220429"},{"key":"2948_CR46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1468-1331.2007.01686.x","volume":"14","author":"Drake","year":"2007","unstructured":"Drake AK, Loy CT, Brew BJ et al (2007) Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival. Eur J Neurol 14(4):418\u2013423","journal-title":"Eur J Neurol"},{"key":"2948_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"Engsig","year":"2009","unstructured":"Engsig FN, Hansen AB, Omland LH et al (2009) Incidence, clinical presentation and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199(1):77\u201383","journal-title":"J Infect Dis"},{"key":"2948_CR48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1212\/01.wnl.0000233918.21986.9c","volume":"67","author":"Eng","year":"2006","unstructured":"Eng PM, Turnbull BR, Cook SF et al (2006) Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 67(5):884\u2013886","journal-title":"Neurology"},{"key":"2948_CR49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","volume":"338","author":"Hall","year":"1998","unstructured":"Hall CD, Dafni U, Simpson D et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338(19):1345\u20131351","journal-title":"N Engl J Med"},{"key":"2948_CR50","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","volume":"22","author":"De","year":"2008","unstructured":"De Luca A, Ammassari A, Pezzotti P et al (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22(14):1759\u20131767","journal-title":"AIDS"},{"key":"2948_CR51","doi-asserted-by":"crossref","unstructured":"Kraemer C, Evers S, Nolting T et al (2008) Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. J Neurol","DOI":"10.1007\/s00415-008-0731-z"},{"key":"2948_CR52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.410200304","volume":"20","author":"Gabuzda","year":"1986","unstructured":"Gabuzda DH, Ho DD, Monte SM de la et al (1986) Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20(3):289\u2013295","journal-title":"Ann Neurol"},{"key":"2948_CR53","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00115-008-2588-x","volume":"79","author":"Arendt","year":"2008","unstructured":"Arendt G, Nolting T (2008) Neurological complications of HIV infection. Nervenarzt 79(12):1449\u20131462; 1463","journal-title":"Nervenarzt"},{"key":"2948_CR54","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1148\/rg.287085135","volume":"28","author":"Smith","year":"2008","unstructured":"Smith AB, Smirniotopoulos JG, Rushing EJ (2008) From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 28(7):2033\u20132058","journal-title":"Radiographics"},{"key":"2948_CR55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/BOR.0b013e32831cf5e6","volume":"21","author":"Hajj-Ali","year":"2009","unstructured":"Hajj-Ali RA, Calabrese LH (2009) Central nervous system vasculitis. Curr Opin Rheumatol 21(1):10\u201318","journal-title":"Curr Opin Rheumatol"},{"key":"2948_CR56","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneurol.2009.76","volume":"66","author":"Birnbaum","year":"2009","unstructured":"Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66(6):704\u2013709","journal-title":"Arch Neurol"},{"key":"2948_CR57","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","volume":"62","author":"Salvarani","year":"2007","unstructured":"Salvarani C, Brown RD Jr, Calamia KT et al (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62(5):442\u2013451","journal-title":"Ann Neurol"},{"key":"2948_CR58","doi-asserted-by":"crossref","unstructured":"Salvarani C, Brown RD Jr, Calamia KT et al (2008) Primary CNS vasculitis with spinal cord involvement. Neurology 70(24\/2):2394\u20132400","DOI":"10.1212\/01.wnl.0000314687.69681.24"},{"key":"2948_CR59","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3174\/ajnr.A1532","volume":"30","author":"Yahyavi-Firouz-Abadi","year":"2009","unstructured":"Yahyavi-Firouz-Abadi N, Wynn BL, Rybicki FJ et al (2009) Steroid-responsive large vessel vasculitis: application of whole-brain 320-detector row dynamic volume CT angiography and perfusion. AJNR Am J Neuroradiol 30(7):1409\u20131411","journal-title":"AJNR Am J Neuroradiol"},{"key":"2948_CR60","unstructured":"Rossi CM, Di Comite G (2009) The clinical spectrum of the neurological involvement in vasculitides. J Neurol Sci 285(1\u20132):13\u201321"},{"key":"2948_CR61","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3174\/ajnr.A0663","volume":"28","author":"White","year":"2007","unstructured":"White ML, Hadley WL, Zhang Y, Dogar MA (2007) Analysis of central nervous system vasculitis with diffusion-weighted imaging and apparent diffusion coefficient mapping of the normal-appearing brain. AJNR Am J Neuroradiol 28(5):933\u2013937","journal-title":"AJNR Am J Neuroradiol"},{"key":"2948_CR62","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.37.6.1072","volume":"37","author":"Rubin","year":"1987","unstructured":"Rubin AM, Kang H (1987) Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 37(6):1072\u20131076","journal-title":"Neurology"},{"key":"2948_CR63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494\u2013500","journal-title":"N Engl J Med"},{"key":"2948_CR64","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00115-006-2132-9","volume":"77","author":"Herberger","year":"2006","unstructured":"Herberger S, Linn J, Pfefferkorn T et al (2006) Complexities of \u201ereversible posterior leukoencephalopathy syndrome\u201c. Nervenarzt 77(10):1218\u20131222","journal-title":"Nervenarzt"},{"key":"2948_CR65","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0b013e3181bf98c9","volume":"73","author":"Briganti","year":"2009","unstructured":"Briganti C, Caulo M, Notturno F et al (2009) Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome. Neurology 73(18):1507\u20131508","journal-title":"Neurology"},{"key":"2948_CR66","doi-asserted-by":"crossref","unstructured":"Nagato M, Takahashi Y, Yoshioka M, Nambu M (2009) A case of hypertensive encephalopathy with extensive spinal lesions on MRI. Brain Dev","DOI":"10.1016\/j.braindev.2009.07.002"},{"key":"2948_CR67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00234-009-0504-0","volume":"51","author":"Mueller-Mang","year":"2009","unstructured":"Mueller-Mang C, Mang T, Pirker A et al (2009) Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51(6):373\u2013383","journal-title":"Neuroradiology"},{"key":"2948_CR68","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.1987.03400130096040","volume":"258","author":"Roman","year":"1987","unstructured":"Roman GC (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258(13):1782\u20131788","journal-title":"JAMA"},{"key":"2948_CR69","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","volume":"30","author":"Bartels","year":"2009","unstructured":"Bartels AL, Kortekaas R, Bart J et al (2009) Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging 30(11):1818\u20131824","journal-title":"Neurobiol Aging"},{"key":"2948_CR70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.wnl.0000319691.50117.54","volume":"71","author":"Young","year":"2008","unstructured":"Young VG, Halliday GM, Kril JJ (2008) Neuropathologic correlates of white matter hyperintensities. Neurology 71(11):804\u2013811","journal-title":"Neurology"},{"key":"2948_CR71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.clineuro.2009.08.018","volume":"111","author":"Han","year":"2009","unstructured":"Han JH, Wong KS, Wang YY et al (2009) Plasma level of sICAM-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects. Clin Neurol Neurosurg 111(10):847\u2013851","journal-title":"Clin Neurol Neurosurg"},{"key":"2948_CR72","unstructured":"Sch\u00f6ls L, Boesch S, K\u00f6hler W et al (2008) Leukodystrophien im Erwachsenenalter. In: Diener HC, Putzk IN (Hrsg) Georg Thieme, Stuttgart"},{"key":"2948_CR73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/humu.1227","volume":"18","author":"Kemp","year":"2001","unstructured":"Kemp S, Pujol A, Waterham HR et al (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 18(6):499\u2013515","journal-title":"Hum Mutat"},{"key":"2948_CR74","doi-asserted-by":"crossref","unstructured":"Wichers M, Kohler W, Brennemann W et al (1999) X-linked adrenomyeloneuropathy associated with 14 novel ALD-gene mutations: no correlation between type of mutation and age of onset. Hum Genet 105(1\u20132):116\u2013119","DOI":"10.1007\/s004399900090"},{"key":"2948_CR75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","volume":"5","author":"Knaap","year":"2006","unstructured":"Knaap MS van der, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5(5):413\u2013423","journal-title":"Lancet Neurol"},{"key":"2948_CR76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C","volume":"71","author":"Heim","year":"1997","unstructured":"Heim P, Claussen M, Hoffmann B et al (1997) Leukodystrophy incidence in Germany. Am J Med Genet 71(4):475\u2013478","journal-title":"Am J Med Genet"},{"key":"2948_CR77","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000343049.00540.c8","volume":"72","author":"Schiffmann","year":"2009","unstructured":"Schiffmann R, Knaap MS van der (2009) Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72(8):750\u2013759","journal-title":"Neurology"},{"key":"2948_CR78","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3174\/ajnr.A1694","volume":"30","author":"Uggetti","year":"2009","unstructured":"Uggetti C, La Piana R, Orcesi S et al (2009) Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up. AJNR Am J Neuroradiol 30(10):1971\u20131976","journal-title":"AJNR Am J Neuroradiol"},{"key":"2948_CR79","doi-asserted-by":"crossref","unstructured":"Uluc K, Baskan O, Yildirim KA et al (2008) Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci 273(1\u20132):118\u2013122","DOI":"10.1016\/j.jns.2008.06.002"},{"key":"2948_CR80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00019052-200106000-00007","volume":"14","author":"Berger","year":"2001","unstructured":"Berger J, Moser HW, Forss-Petter S (2001) Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol 14(3):305\u2013312","journal-title":"Curr Opin Neurol"},{"key":"2948_CR81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10545-008-0778-0","volume":"31","author":"Sedel","year":"2008","unstructured":"Sedel F, Tourbah A, Fontaine B et al (2008) Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis 31(3):295\u2013307","journal-title":"J Inherit Metab Dis"},{"key":"2948_CR82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L","volume":"76","author":"Bezman","year":"1998","unstructured":"Bezman L, Moser HW (1998) Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet 76(5):415\u2013419","journal-title":"Am J Med Genet"},{"key":"2948_CR83","unstructured":"Moser HW, Smith KD, Watkins PA et al (2000) The metabolic and molecular bases of inherited disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) McGraw Hill, New York"},{"key":"2948_CR84","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","volume":"45","author":"Moser","year":"1999","unstructured":"Moser AB, Kreiter N, Bezman L et al (1999) Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol 45(1):100\u2013110","journal-title":"Ann Neurol"},{"key":"2948_CR85","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/0883073809338327","volume":"24","author":"Singh","year":"2009","unstructured":"Singh I, Singh AK, Contreras MA (2009) Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology. J Child Neurol 24(9):1147\u20131157","journal-title":"J Child Neurol"},{"key":"2948_CR86","doi-asserted-by":"crossref","unstructured":"K\u00f6hler W (2008) Diagnostic algorithm for the differentiation of leukodystrophies in early MS. J Neurol 255 [Suppl 6]:123\u2013126","DOI":"10.1007\/s00415-008-6023-9"},{"key":"2948_CR87","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","volume":"49","author":"Geel","year":"2001","unstructured":"Geel BM van, Bezman L, Loes DJ et al (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49(2):186\u2013194","journal-title":"Ann Neurol"},{"key":"2948_CR88","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpneuro0421","volume":"3","author":"Moser","year":"2007","unstructured":"Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3(3):140\u2013151","journal-title":"Nat Clin Pract Neurol"},{"key":"2948_CR89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326(5954):818\u2013823","journal-title":"Science"},{"key":"2948_CR90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/NRL.0b013e31815b0de2","volume":"14","author":"Bonelli","year":"2008","unstructured":"Bonelli RM, Cummings JL (2008) Frontal-subcortical dementias. Neurologist 14(2):100\u2013107","journal-title":"Neurologist"},{"key":"2948_CR91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1023\/A:1005685010766","volume":"23","author":"Estrov","year":"2000","unstructured":"Estrov Y, Scaglia F, Bodamer OA (2000) Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis 23(1):2\u20136","journal-title":"J Inherit Metab Dis"},{"key":"2948_CR92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archneur.1992.00530280095028","volume":"49","author":"Hyde","year":"1992","unstructured":"Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol 49(4):401\u2013406","journal-title":"Arch Neurol"},{"key":"2948_CR93","unstructured":"Figura K von, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Valle D (eds) McGraw-Hill, New York"},{"key":"2948_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mgme.2000.2990","volume":"70","author":"Wenger","year":"2000","unstructured":"Wenger DA, Rafi MA, Luzi P et al (2000) Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab 70(1):1\u20139","journal-title":"Mol Genet Metab"},{"key":"2948_CR95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/01.WNL.0000134651.38196.F8","volume":"63","author":"Husain","year":"2004","unstructured":"Husain AM, Altuwaijri M, Aldosari M (2004) Krabbe disease: neurophysiologic studies and MRI correlations. Neurology 63(4):617\u2013620","journal-title":"Neurology"},{"key":"2948_CR96","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0404.2007.00867.x","volume":"116","author":"Wang","year":"2007","unstructured":"Wang C, Melberg A, Weis J et al (2007) The earliest MR imaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease. Acta Neurol Scand 116(4):268\u2013272","journal-title":"Acta Neurol Scand"},{"key":"2948_CR97","first-page":"939","volume":"37","author":"Tullu","year":"2000","unstructured":"Tullu MS, Muranjan MN, Kondurkar PP, Bharucha BA (2000) Krabbe disease\u2013clinical profile. Indian Pediatr 37(9):939\u2013946","journal-title":"Indian Pediatr"},{"key":"2948_CR98","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1373\/clinchem.2008.115873","volume":"55","author":"Martino","year":"2009","unstructured":"Martino S, Tiribuzi R, Tortori A et al (2009) Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase. Clin Chem 55(3):541\u2013548","journal-title":"Clin Chem"},{"key":"2948_CR99","first-page":"299","volume":"124","author":"Zakharova","year":"2008","unstructured":"Zakharova E, Boukina TM (2008) Gene symbol: GALC. disease: Krabbe disease. Hum Genet 124(3):299","journal-title":"Hum Genet"},{"key":"2948_CR100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mus.20535","volume":"34","author":"D","year":"2006","unstructured":"D\u2019Angelo MG, Bresolin N (2006) Cognitive impairment in neuromuscular disorders. Muscle Nerve 34(1):16\u201333","journal-title":"Muscle Nerve"},{"key":"2948_CR101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mds.20285","volume":"20","author":"Krim","year":"2005","unstructured":"Krim E, Vital A, Macia F et al (2005) Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease. Mov Disord 20(2):200\u2013204","journal-title":"Mov Disord"},{"key":"2948_CR102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","volume":"2","author":"Moses","year":"2002","unstructured":"Moses SW, Parvari R (2002) The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr Mol Med 2(2):177\u2013188","journal-title":"Curr Mol Med"},{"key":"2948_CR103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002340000425","volume":"43","author":"Berkhoff","year":"2001","unstructured":"Berkhoff M, Weis J, Schroth G, Sturzenegger M (2001) Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology 43(3):234\u2013236","journal-title":"Neuroradiology"},{"key":"2948_CR104","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng0393-256","volume":"3","author":"Tournier-Lasserve","year":"1993","unstructured":"Tournier-Lasserve E, Joutel A, Melki J et al (1993) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3(3):256\u2013259","journal-title":"Nat Genet"},{"key":"2948_CR105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410440506","volume":"44","author":"Dichgans","year":"1998","unstructured":"Dichgans M, Mayer M, Uttner I et al (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44(5):731\u2013739","journal-title":"Ann Neurol"},{"key":"2948_CR106","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/383707a0","volume":"383","author":"Joutel","year":"1996","unstructured":"Joutel A, Corpechot C, Ducros A et al (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(6602):707\u2013710","journal-title":"Nature"},{"key":"2948_CR107","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","volume":"8","author":"Chabriat","year":"2009","unstructured":"Chabriat H, Joutel A, Dichgans M et al (2009) Cadasil. Lancet Neurol 8(7):643\u2013653","journal-title":"Lancet Neurol"},{"key":"2948_CR108","unstructured":"Viswanathan A, Godin O, Jouvent E et al (2008) Impact of MRI markers in subcortical vascular dementia: A multi-modal analysis in CADASIL. Neurobiol Aging"},{"key":"2948_CR109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(07)70028-5","volume":"6","author":"Dichgans","year":"2007","unstructured":"Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6(2):149\u2013161","journal-title":"Lancet Neurol"},{"key":"2948_CR110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/STROKEAHA.107.490672","volume":"39","author":"Benisty","year":"2008","unstructured":"Benisty S, Hernandez K, Viswanathan A et al (2008) Diagnostic criteria of vascular dementia in CADASIL. Stroke 39(3):838\u2013844","journal-title":"Stroke"},{"key":"2948_CR111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00415-006-0306-9","volume":"254","author":"Riecker","year":"2007","unstructured":"Riecker A, Nagele T, Henneke M, Schols L (2007) Late onset vanishing white matter disease. J Neurol 254(4):544\u2013545","journal-title":"J Neurol"},{"key":"2948_CR112","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ng2013","volume":"39","author":"Scheper","year":"2007","unstructured":"Scheper GC, Klok T van der, Andel RJ van et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39(4):534\u2013539","journal-title":"Nat Genet"},{"key":"2948_CR113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2003-42210","volume":"34","author":"Blattner","year":"2003","unstructured":"Blattner R, Von Moers A, Leegwater PA et al (2003) Clinical and genetic heterogeneity in megalencephalic leukoencephalopathy with subcortical cysts (MLC). Neuropediatrics 34(4):215\u2013218","journal-title":"Neuropediatrics"},{"key":"2948_CR114","doi-asserted-by":"crossref","unstructured":"Jerbi Omezzine S, Ben Ameur H, Bousoffara R et al (2008) Megalencephalic leukoencephalopathy with subcortical cysts: report of 4 new cases. J Radiol 89(7\u20138\/1):891\u2013894","DOI":"10.1016\/S0221-0363(08)73877-0"},{"key":"2948_CR115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.20773","volume":"59","author":"Ptacek","year":"2006","unstructured":"Ptacek LJ, Fu YH, Koeppen A (2006) The dominant form of vanishing white matter-like leukoencephalopathy represents autosomal dominant leukodystrophy. Ann Neurol 59(2):434","journal-title":"Ann Neurol"},{"key":"2948_CR116","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM198410113111504","volume":"311","author":"Eldridge","year":"1984","unstructured":"Eldridge R, Anayiotos CP, Schlesinger S et al (1984) Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med 311(15):948\u2013953","journal-title":"N Engl J Med"},{"key":"2948_CR117","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ng1872","volume":"38","author":"Padiath","year":"2006","unstructured":"Padiath QS, Saigoh K, Schiffmann R et al (2006) Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38(10):1114\u20131123","journal-title":"Nat Genet"},{"key":"2948_CR118","first-page":"904","volume":"27","author":"Melberg","year":"2006","unstructured":"Melberg A, Hallberg L, Kalimo H, Raininko R (2006) MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol 27(4):904\u2013911","journal-title":"AJNR Am J Neuroradiol"},{"key":"2948_CR119","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00588038","volume":"33","author":"Knaap","year":"1991","unstructured":"Knaap MS van der, Valk J, Neeling N de, Nauta JJ (1991) Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology 33(6):478\u2013493","journal-title":"Neuroradiology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2948-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-2948-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2948-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T09:07:11Z","timestamp":1591175231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-2948-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,27]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-2948-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,27]]}}}